154 related articles for article (PubMed ID: 37531109)
21. Obesity and risk of non-Hodgkin lymphoma (United States).
Chiu BC; Soni L; Gapstur SM; Fought AJ; Evens AM; Weisenburger DD
Cancer Causes Control; 2007 Aug; 18(6):677-85. PubMed ID: 17484069
[TBL] [Abstract][Full Text] [Related]
22. Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.
Rollison DE; Engels EA; Halsey NA; Shah KV; Viscidi RP; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):543-50. PubMed ID: 16537714
[TBL] [Abstract][Full Text] [Related]
23. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.
Albanes D; Heinonen OP; Taylor PR; Virtamo J; Edwards BK; Rautalahti M; Hartman AM; Palmgren J; Freedman LS; Haapakoski J; Barrett MJ; Pietinen P; Malila N; Tala E; Liippo K; Salomaa ER; Tangrea JA; Teppo L; Askin FB; Taskinen E; Erozan Y; Greenwald P; Huttunen JK
J Natl Cancer Inst; 1996 Nov; 88(21):1560-70. PubMed ID: 8901854
[TBL] [Abstract][Full Text] [Related]
24. Occupational risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Northern Germany.
Richardson DB; Terschüren C; Hoffmann W
Am J Ind Med; 2008 Apr; 51(4):258-68. PubMed ID: 18213641
[TBL] [Abstract][Full Text] [Related]
25. Tobacco use and non-Hodgkin lymphoma: results from a population-based case-control study in the San Francisco Bay Area, California.
Bracci PM; Holly EA
Cancer Causes Control; 2005 May; 16(4):333-46. PubMed ID: 15953976
[TBL] [Abstract][Full Text] [Related]
26. Erythrocyte levels of cadmium and lead and risk of B-cell non-Hodgkin lymphoma and multiple myeloma.
Deubler EL; Gapstur SM; Diver WR; Gaudet MM; Hodge JM; Stevens VL; McCullough ML; Haines LG; Levine KE; Teras LR
Int J Cancer; 2020 Dec; 147(11):3110-3118. PubMed ID: 32506449
[TBL] [Abstract][Full Text] [Related]
27. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.
Purdue MP; Lan Q; Bagni R; Hocking WG; Baris D; Reding DJ; Rothman N
Cancer Res; 2011 Jul; 71(14):4898-907. PubMed ID: 21632552
[TBL] [Abstract][Full Text] [Related]
28. Prediagnostic serum tocopherol levels and the risk of non-hodgkin lymphoma: the multiethnic cohort.
Morimoto Y; Ollberding NJ; Cooney RV; Wilkens LR; Franke AA; Le Marchand L; Goodman MT; Hernandez BY; Kolonel LN; Maskarinec G
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2075-83. PubMed ID: 24045922
[TBL] [Abstract][Full Text] [Related]
29. Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma.
Chiu BC; Kwon S; Evens AM; Surawicz T; Smith SM; Weisenburger DD
Cancer Causes Control; 2011 Aug; 22(8):1183-95. PubMed ID: 21695384
[TBL] [Abstract][Full Text] [Related]
30. Birth order, atopy, and risk of non-Hodgkin lymphoma.
Grulich AE; Vajdic CM; Kaldor JM; Hughes AM; Kricker A; Fritschi L; Turner JJ; Milliken S; Benke G; Armstrong BK
J Natl Cancer Inst; 2005 Apr; 97(8):587-94. PubMed ID: 15840881
[TBL] [Abstract][Full Text] [Related]
31. Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study.
Kelemen LE; Cerhan JR; Lim U; Davis S; Cozen W; Schenk M; Colt J; Hartge P; Ward MH
Am J Clin Nutr; 2006 Jun; 83(6):1401-10. PubMed ID: 16762953
[TBL] [Abstract][Full Text] [Related]
32. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).
Wang SS; Slager SL; Brennan P; Holly EA; De Sanjose S; Bernstein L; Boffetta P; Cerhan JR; Maynadie M; Spinelli JJ; Chiu BC; Cocco PL; Mensah F; Zhang Y; Nieters A; Dal Maso L; Bracci PM; Costantini AS; Vineis P; Severson RK; Roman E; Cozen W; Weisenburger D; Davis S; Franceschi S; La Vecchia C; Foretova L; Becker N; Staines A; Vornanen M; Zheng T; Hartge P
Blood; 2007 Apr; 109(8):3479-88. PubMed ID: 17185468
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
[TBL] [Abstract][Full Text] [Related]
34. Household endotoxin levels and the risk of non-Hodgkin lymphoma.
Wang J; Cozen W; Thorne PS; Berhane K; Cerhan JR; Hartge P; Ward MH; De Roos AJ; Severson RK; Morton LM; Bernstein L; Linet MS; Colt JS
Cancer Causes Control; 2013 Feb; 24(2):357-64. PubMed ID: 23277417
[TBL] [Abstract][Full Text] [Related]
35. Long-term exposure to air pollution and risk of non-Hodgkin lymphoma in Denmark: A population-based case-control study.
Taj T; Poulsen AH; Ketzel M; Geels C; Brandt J; Christensen JH; Puett R; Hvidtfeldt UA; Sørensen M; Raaschou-Nielsen O
Int J Cancer; 2020 Oct; 147(7):1874-1880. PubMed ID: 32175588
[TBL] [Abstract][Full Text] [Related]
36. Mode of Delivery, Birth Characteristics, and Early-Onset Non-Hodgkin Lymphoma in a Population-Based Case-Control Study.
Dwyer KE; Wang R; Cozen W; Cartmel B; Wiemels JL; Morimoto LM; Metayer C; Ma X
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2286-2293. PubMed ID: 34548330
[TBL] [Abstract][Full Text] [Related]
37. LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk.
Karami S; Andreotti G; Liao LM; Pfeiffer RM; Weinstein SJ; Purdue MP; Hofmann JN; Albanes D; Mannisto S; Moore LE
Epigenetics; 2015; 10(4):282-92. PubMed ID: 25647181
[TBL] [Abstract][Full Text] [Related]
38. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use.
Lee JS; Bracci PM; Holly EA
Am J Epidemiol; 2008 Aug; 168(3):278-88. PubMed ID: 18550561
[TBL] [Abstract][Full Text] [Related]
39. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants.
Andreotti G; Karami S; Pfeiffer RM; Hurwitz L; Liao LM; Weinstein SJ; Albanes D; Virtamo J; Silverman DT; Rothman N; Moore LE
Epigenetics; 2014 Mar; 9(3):404-15. PubMed ID: 24316677
[TBL] [Abstract][Full Text] [Related]
40. Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort.
Rollison DE; Helzlsouer KJ; Halsey NA; Shah KV; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1448-52. PubMed ID: 15941954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
